Scilex Holding announced that many national pharmacy chains and independent pharmacy stores have begun stocking GLOPERBA Scilex launched GLOPERBA, an FDA-approved prophylactic treatment for painful gout flares in adults in the U.S., on June 10, 2024
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCLX:
- Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.
- Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024
- Scilex says FDA approval of Gloperba commercial manufacturing
- Scilex Alerts Regulators to Illegal Stock Manipulation
- Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company